Marianna Abrok
Overview
Explore the profile of Marianna Abrok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gajdacs M, Abrok M, Lazar A, Burian K
Antibiotics (Basel)
. 2021 Sep;
10(9).
PMID: 34572680
The ageing of the population-especially in developed countries-has brought on many societal challenges and has significantly contributed to the burden on healthcare infrastructures worldwide. Elderly persons (aged ≥ 65 years)...
2.
Gajdacs M, Abrok M, Lazar A, Burian K
Biol Futur
. 2021 Sep;
71(1-2):175-182.
PMID: 34554531
Urinary tract infections (UTIs) are some of the most common infections affecting humans worldwide. Occurrence of atypical, lactose non-fermenting, biochemically "inactive" strains of E. coli in clinical material has been...
3.
Gajdacs M, Abrok M, Lazar A, Burian K
Infect Drug Resist
. 2021 Jan;
13:4739-4749.
PMID: 33408489
Introduction: Pyogenic β-hemolytic streptococci (including Group A, C and G ) are some of the most important Gram-positive bacterial pathogens in human medicine. Although effective therapy is available, invasive streptococcal...
4.
Gajdacs M, Abrok M, Lazar A, Janvari L, Toth A, Terhes G, et al.
Acta Microbiol Immunol Hung
. 2020 Dec;
67(4):209-215.
PMID: 33258795
Infections caused by carbapenem-resistant Enterobacterales (CRE) present an important therapeutic problem, as there are limited number of effective therapeutic alternatives available. In this study, phenotypic and genotypic methods were used...
5.
Gajdacs M, Abrok M, Lazar A, Burian K
Sci Rep
. 2020 Oct;
10(1):17658.
PMID: 33077890
Urinary tract infections (UTIs) are the third most common types of infection in human medicine worldwide. There is increasing appreciation for the pathogenic role of Gram-positive cocci (GPC) in UTIs,...
6.
Gajdacs M, Abrok M, Lazar A, Terhes G, Burian K
J Infect Dev Ctries
. 2020 Oct;
14(9):1004-1010.
PMID: 33031089
Introduction: The clinical role of Leclercia adecarboxylata as an opportunistic pathogen in the context of human infections have been highlighted by multiple published case reports, describing these bacteria as novel...
7.
Gajdacs M, Abrok M, Lazar A, Terhes G, Urban E
Anaerobe
. 2020 Apr;
63:102200.
PMID: 32247001
Anaerobic bacteremia (AB) is usually detected in about 0.5-13% of positive blood cultures. The aim of this study was to determine prevalence of anaerobic bacteremia over a 5-year period (2013-2017),...
8.
Gajdacs M, Batori Z, Abrok M, Lazar A, Burian K
Life (Basel)
. 2020 Feb;
10(2).
PMID: 32054054
Classical resistance classifications (multidrug resistance [MDR], extensive drug resistance [XDR], pan-drug resistance [PDR]) are very useful for epidemiological purposes, however, they may not correlate well with clinical outcomes, therefore, several...
9.
Abrok M, Tigyi P, Kostrzewa M, Burian K, Deak J
Pathogens
. 2019 Dec;
9(1).
PMID: 31861306
Pregnant women colonized by or group B streptococcus (GBS), are at an increased risk of premature delivery and stillbirth, and their neonates can be endangered by the development of an...
10.
Gajdacs M, Doczi I, Abrok M, Lazar A, Burian K
Cent European J Urol
. 2019 Sep;
72(2):209-214.
PMID: 31482032
Introduction: The presence of Candida species in urine (candiduria) is a common clinical finding, which may frequently represent colonization or contamination of specimens, however, they may be etiological agents in...